| Dr Margot Boigon, MD | |
|
1245 Highland Ave, Ste 302, Abington, PA 19001-3724 | |
| (215) 517-8850 | |
| Not Available |
| Full Name | Dr Margot Boigon |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 34 Years |
| Location | 1245 Highland Ave, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811993140 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD048920L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abington Memorial Hospital | Abington, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
| Methodist Associates In Healthcare, Inc | 6406755651 | 264 |
| Amh Medical Staff Service Fund | 9830003813 | 42 |
News Archive
Politico: During a Friday meeting with Democratic members, Pelosi told lawmakers to "clear their schedules for next weekend." She also promised "to stay in session until the landmark vote, people present said afterwards."
The best approach for surgeons to identify malnourished cancer patients before they have a cancer operation may be specifically related to the type of cancer the patient has, according to researchers who found that common definitions of malnutrition do not apply equally to all cancers in assessment of preoperative risk.
Early use of thrust manipulation does not offer improved outcomes and a quicker recovery from low-back pain compared with nonthrust techniques, US study findings suggest.
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
› Verified 2 days ago
| Entity Name | Amh Medical Staff Service Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356384457 PECOS PAC ID: 9830003813 Enrollment ID: O20031114000011 |
News Archive
Politico: During a Friday meeting with Democratic members, Pelosi told lawmakers to "clear their schedules for next weekend." She also promised "to stay in session until the landmark vote, people present said afterwards."
The best approach for surgeons to identify malnourished cancer patients before they have a cancer operation may be specifically related to the type of cancer the patient has, according to researchers who found that common definitions of malnutrition do not apply equally to all cancers in assessment of preoperative risk.
Early use of thrust manipulation does not offer improved outcomes and a quicker recovery from low-back pain compared with nonthrust techniques, US study findings suggest.
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
› Verified 2 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063526556 PECOS PAC ID: 3274437736 Enrollment ID: O20040330000678 |
News Archive
Politico: During a Friday meeting with Democratic members, Pelosi told lawmakers to "clear their schedules for next weekend." She also promised "to stay in session until the landmark vote, people present said afterwards."
The best approach for surgeons to identify malnourished cancer patients before they have a cancer operation may be specifically related to the type of cancer the patient has, according to researchers who found that common definitions of malnutrition do not apply equally to all cancers in assessment of preoperative risk.
Early use of thrust manipulation does not offer improved outcomes and a quicker recovery from low-back pain compared with nonthrust techniques, US study findings suggest.
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
› Verified 2 days ago
| Entity Name | Methodist Associates In Healthcare, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053355131 PECOS PAC ID: 6406755651 Enrollment ID: O20040402000835 |
News Archive
Politico: During a Friday meeting with Democratic members, Pelosi told lawmakers to "clear their schedules for next weekend." She also promised "to stay in session until the landmark vote, people present said afterwards."
The best approach for surgeons to identify malnourished cancer patients before they have a cancer operation may be specifically related to the type of cancer the patient has, according to researchers who found that common definitions of malnutrition do not apply equally to all cancers in assessment of preoperative risk.
Early use of thrust manipulation does not offer improved outcomes and a quicker recovery from low-back pain compared with nonthrust techniques, US study findings suggest.
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Margot Boigon, MD 1245 Highland Ave, Ste 302, Abington, PA 19001-3724 Ph: (215) 517-8850 | Dr Margot Boigon, MD 1245 Highland Ave, Ste 302, Abington, PA 19001-3724 Ph: (215) 517-8850 |
News Archive
Politico: During a Friday meeting with Democratic members, Pelosi told lawmakers to "clear their schedules for next weekend." She also promised "to stay in session until the landmark vote, people present said afterwards."
The best approach for surgeons to identify malnourished cancer patients before they have a cancer operation may be specifically related to the type of cancer the patient has, according to researchers who found that common definitions of malnutrition do not apply equally to all cancers in assessment of preoperative risk.
Early use of thrust manipulation does not offer improved outcomes and a quicker recovery from low-back pain compared with nonthrust techniques, US study findings suggest.
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
› Verified 2 days ago
Dr. Shaili Nepal, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2191 Fax: 215-481-3411 | |
Muhammad Arslan Asghar Cheema, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2222 Fax: 215-481-4361 | |
Margaret Mack, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Joseph Guererri Crocetti Jr., DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Ste 121, Abington, PA 19001 Phone: 215-517-1200 Fax: 215-517-1219 | |
Dr. Joseph Mcallister, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Ste 113, Abington, PA 19001 Phone: 215-517-1180 | |
William L. Ward, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Suite 121, Abington, PA 19001 Phone: 215-517-1200 Fax: 215-517-1219 | |
Rebecca Jane Fallis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd Ste 220, Abington, PA 19001 Phone: 215-481-6350 Fax: 215-481-4237 |